Literature DB >> 10665893

Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia.

J A Ramirez1, S Vargas, G W Ritter, M E Brier, A Wright, S Smith, D Newman, J Burke, M Mushtaq, A Huang.   

Abstract

UNLABELLED: To determine the proportion of patients who can be treated with early switch to oral antibiotics and early discharge, to evaluate clinical outcome and patient satisfaction for patients treated with early switch and early discharge, and to define the factors that interfere with early discharge for some of the patients who underwent early switch to oral antibiotic therapy.
DESIGN: Prospective study. PARTICIPANTS: Two hundred consecutive hospitalized patients with community-acquired pneumonia. MAIN OUTCOME MEASURES: Number of days needed to switch to oral therapy and length of hospital stay. Clinical outcome and satisfaction with care were evaluated for those patients treated with early switch and early discharge.
RESULTS: Early switch to oral antibiotics (within the first 3 days of hospitalization) was performed in 133 patients (67%). Clinical failure was documented in 1 patient. Early switch and early discharge was performed in 88 patients (44%). The mean length of hospital stay for this group was 3.4 days. The most common reason for prolonged hospitalization after the switch to oral antibiotics was the need for diagnostic workup. More than 95% of patients were satisfied with the care they had received.
CONCLUSIONS: Using simple clinical and laboratory criteria, a significant proportion of hospitalized patients with community-acquired pneumonia (44%) can be treated with early switch and early discharge. This model did not affect patient outcome, decreased the length of hospitalization, and was associated with a high level of patient satisfaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10665893     DOI: 10.1001/archinte.159.20.2449

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  41 in total

1.  Management strategies for community acquired pneumonia.

Authors:  M Hasnain; E J Clark
Journal:  J Med Syst       Date:  2000-10       Impact factor: 4.460

Review 2.  Bacteraemic pneumococcal pneumonia: current therapeutic options.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

3.  Empiric oral monotherapy for hospitalized patients with community-acquired pneumonia: an idea whose time has come.

Authors:  B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-15       Impact factor: 3.267

4.  Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia.

Authors:  V Erard; O Lamy; P-Y Bochud; J Bille; A Cometta; T Calandra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-15       Impact factor: 3.267

5.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

6.  Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study.

Authors:  M M van der Eerden; F Vlaspolder; C S de Graaff; T Groot; W Bronsveld; H M Jansen; W G Boersma
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

Review 7.  Changing needs of community-acquired pneumonia.

Authors:  Julio Alberto Ramirez; Antonio R Anzueto
Journal:  J Antimicrob Chemother       Date:  2011-04       Impact factor: 5.790

8.  Modern Management of Community-Acquired Pneumonia: Is It Cost-Effective and are Outcomes Acceptable?

Authors:  Dominik Mertz; Jennie Johnstone
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

Review 9.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Outcomes of early switching from intravenous to oral antibiotics on medical wards.

Authors:  Dominik Mertz; Michael Koller; Patricia Haller; Markus L Lampert; Herbert Plagge; Balthasar Hug; Gian Koch; Manuel Battegay; Ursula Flückiger; Stefano Bassetti
Journal:  J Antimicrob Chemother       Date:  2009-04-28       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.